Publications
Review Article
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
Measuring Human Immunity
2017
Authors:
Gnjatic S, Bronte V, Brunet LR, Butler MO, Disis ML, Galon J, Hakansson LG, Hanks BA, Karanikas V, Khleif SN, Kirkwood JM, Miller LD, Schendel DJ, Tanneau I, Wigginton JM, Butterfield LH.
Journal:
Journal of Immunotherapy of cancer
Pubmed:
Volume:
5
Page:
44
Review Article
Expanding assessments of translational research programs: supplementing metrics with value judgments
Measuring Human Immunity
2013
Authors:
Scott, C.S., Nagasawa, P., Disis, M.L., Ramsey, B.W., Martin, P., Abernathy, N., Hacker, B.M., and Schwartz H.
Journal:
Evaluation and Health Professions
Pubmed:
Volume:
37(1)
Page:
83-97
Review Article
ELISpot for measuring human immune responses to vaccines
Measuring Human Immunity
2011
Authors:
Slota M, Lim JB, Dang Y, Disis ML.
Journal:
Expert Review of Vaccine
Pubmed:
Volume:
10(3)
Page:
299-306
Review Article
Immunologic biomarkers as correlates of clinical response to cancer immunotherapy
Measuring Human Immunity
2011
Authors:
Disis, M.L..
Journal:
Cancer Immunology Immunotherapy
Pubmed:
Volume:
60(3)
Page:
433-43
Original Article
Identification of immunologic biomarkers associated with clinical response after immune-based therapy for cancer
Measuring Human Immunity
2009
Authors:
Dang Y and Disis ML
Journal:
Annals of the New York Academy of Sciences
Pubmed:
Volume:
1174
Page:
81-7
Original Article
An analytical workflow for investigating cytokine profiles
Measuring Human Immunity
2008
Authors:
Siebert JC, Inokuma M, Waid DM, Pennock ND, Vaitaitis GM, Disis ML, Dunne JF, Wagner DH and Maecker HT
Journal:
Cytometry A
Pubmed:
Volume:
73(4)
Page:
289-98
Methods
Precision and linearity targets for validation of an IFNγ ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides
Measuring Human Immunity
2008
Authors:
Maecker HT, Hassler J, Payne JK, Summers A, Comatas K, Ghanayem M, Morse MA, Clay TM, Lyerly HK, Bhatia S, Ghanekar SA, Maino VC, delaRosa C and Disis ML
Journal:
BMC Immunology
Pubmed:
Volume:
9
Page:
9
Review Article
A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"
Measuring Human Immunity
2008
Authors:
Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Thurin M, Trinchieri G, Wang E, Wigginton J, Chaussabel D, Coukos G, Dhodapkar M, Hakansson L, Janetzki S, Kleen TO, Kirkwood JM, Maccalli C, Maecker H, Maio M, Malyguine A, Masucci G, Palucka AK, Potter DM, Ribas A, Rivoltini L, Schendel D, Seliger B, Selvan S, Slingluff CL Jr, Stroncek DF, StreicherH, Wu X, Zeskind B, Zhao Y, Zocca MB, Zwierzina H, Marincola FM.
Journal:
Journal of Translational Medicine
Pubmed:
Volume:
6
Page:
81
Methods
Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responses
Measuring Human Immunity
2007
Authors:
Goodell V, dela Rosa C, Slota M, MacLeod B and Disis ML
Journal:
BMC Immunology
Pubmed:
Volume:
8
Page:
21
Original Article
Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors
Measuring Human Immunity
2007
Authors:
Ghanekar SA, Bhatia S, Ruitenberg JJ, delaRosa C, Disis ML, Maino VC, Maeker HT and Waters CA
Journal:
Journal of Immune Based Therapies and Vaccines
Pubmed:
Volume:
5
Page:
7